This inventor holds 1 USPTO granted patent and 5 published patent applications and 1 EPO patent. Top assignee: Amgen Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Fernando Alvarez-Nunez: Innovator in Pediatric Formulations
Introduction
Fernando Alvarez-Nunez is an inventor based in Newbury Park, CA (US). He is currently associated with Amgen Inc., a leading biotechnology company. Although he does not hold any granted patents, he is actively involved in the development of innovative pediatric formulations.
Latest Patent Applications
Fernando's latest patent applications include two significant formulations. The first application is for a pediatric formulation of (R)—N-[-1-(1-naphthyl)-ethyl]-343-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride, commonly referred to as Cinacalcet HCl. This invention focuses on the method of administering this formulation to pediatric patients. The second application is for a similar pediatric formulation of (R)-N-[-1-(1-naphthyl)-ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride, also known as Cinacalcet HCl, along with its method of administration.
Conclusion
Fernando Alvarez-Nunez is making strides in the field of pediatric formulations, contributing to the advancement of medical treatments for children. His work at Amgen Inc. highlights his commitment to innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile